FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to experimental surgery, and can be used to prevent bleeding when applying double antiplatelet therapy before surgery. To this end, a solution containing fibrin monomer at a concentration of 11 mg/ml and urea at a concentration of 150 mg/ml is given to a rabbit-male chinchilla one hour before the operation. In this case, the dose of fibrin monomer is 0.25 mg/kg.
EFFECT: method is highly effective, since it not only reduces the amount of blood loss, but also is safe when applied.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING INTRAOPERATIVE BLEEDING CAUSED BY PREOPERATIVE INTRODUCTION OF HEPARINE | 2013 |
|
RU2544805C1 |
| METHOD OF PREVENTION OF BLEEDING CAUSED BY USE OF DABIGATRAN ETEXILATE IN EXPERIMENT | 2013 |
|
RU2552331C1 |
| METHOD OF PREVENTING BLEEDING CAUSED BY USE OF STREPTOKINASE IN EXPERIMENT | 2014 |
|
RU2552339C1 |
| METHOD FOR PREVENTING BLEEDING CAUSED BY USE OF WARFARIN IN EXPERIMENT | 2016 |
|
RU2645414C1 |
| VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR TREATMENT OF COAGULOPATHY, INDUCED BY PLATELET INHIBITORS | 2009 |
|
RU2563236C2 |
| METHOD OF TREATING ACUTE THROMBOSIS OF RETINA VEINS | 2010 |
|
RU2416402C1 |
| FACTOR II AND FIBRINOGEN FOR TREATMENT OF HAEMOSTATIC DISORDERS | 2011 |
|
RU2606155C2 |
| METHOD OF DETERMINING INDICATIONS FOR TRANSFUSION OF PLASMA-COAGULATION HAEMOSTASIS CORRECTORS IN CARDIAC SURGERY | 2014 |
|
RU2568581C1 |
| METHOD FOR PREVENTING HAEMORRHAGE DURING MYOMECTOMY | 2014 |
|
RU2563824C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIAGGREGANT ACTIVITY | 2019 |
|
RU2709017C1 |
